The National Institute of Public Health, the Institute of Haematology
and Blood Transfusion, and the Institute for Clinical and
Experimental Medicine have jointly completed the first state of
developing a vaccine against COVID-19. The vaccine development
cost CZK 4.3m. The results of the first development stage were
published in an international scientific database.